Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.
Also called NCT05122780
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT05122780
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT05122780. Randomized; no masking; primary purpose treatment. Start 2021-07-01 (actual); primary completion 2025-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
- Acronym
- PROMISE
- Condition
- Myocardial Infarction With Non-Obstructive Coronary Arteries
- Intervention (Procedure)
- Coronary angiography
- Intervention (Diagnostic test)
- OCT imaging
- Intervention (Procedure)
- Percutaneous coronary intervention (PCI (percutaneous coronary intervention)):
- Intervention (Diagnostic test)
- Acetylcholine provocative test
- Intervention (Diagnostic test)
- TT-Echocardiography
- Intervention (Diagnostic test)
- TE/contrast echocardiography
- Intervention (Diagnostic test)
- Cardiac magnetic resonance
- Intervention (Diagnostic test)
- Circulating biomarkers
- Intervention (Drug)
- Antiplatelet Drug
- Intervention (Drug)
- Statin
- Intervention (Drug)
- Beta blocker
- Intervention (Drug)
- ACEi/ARB
- Intervention (Drug)
- CCB
- Intervention (Drug)
- Nitrates
- Intervention (Drug)
- Anticoagulant
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Collaborator
- Centro Cardiologico Monzino
- Collaborator
- IRCCS Policlinico S. Donato
Record details
- Record id
cardio:ct-nct05122780- Content hash
1ec334f0f60dddd33d9ec6caf7de13b3e15678ce6be598e197acaaa2bf8b93a2